UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
National Epilepsy Awareness Week is observed every first week of September by virtue of Proclamation No. 230 signed by former President Gloria Macapagal-Arroyo on Aug. 21, 2002--Marielle Medina, Inquirer Research
UCB's (UCBJF) Vimpat has been approved in the U.S. as monotherapy for the treatment of partial-onset seizures in epilepsy patients aged 17 years and above.
A PORTLAND woman has completed a charity walk to raise money for epilepsy research after her nephew died of Dravet Syndrome, a rare and often unmanageable form of epilepsy than begins in infancy and can be fatal.
Katie Hopkins describes the night-time fits that force her to be hospitalised
Washington, Sept 1 (ANI): A new study on mice may help in understanding how brain works, which could open doors in studying epilepsy, alzheimer's and other diseases. University of Utah scientists have developed a...